Results 1 to 10 of about 20,312 (245)

Extraintestinal Clostridioides difficile infection

open access: yesIDCases, 2020
Clostridioides (Clostridium) difficile is the major cause of healthcare antibiotic-associated diarrhoea. However, extra-intestinal manifestations of Clostridioides (Clostridium) difficile infection (CDI) (including bacteremia and tissue infection) are ...
Zhao Hai   +6 more
doaj   +4 more sources

A Review of Therapies for Clostridioides difficile Infection

open access: yesAntibiotics
Clostridioides difficile is an urgent public health threat that affects approximately half a million patients annually in the United States. Despite concerted efforts aimed at the prevention of Clostridioides difficile infection (CDI), it remains a ...
Faiza Morado, Neha Nanda
doaj   +4 more sources

Clostridioides difficile Infection [PDF]

open access: yesRGUHS Journal of Medical Sciences, 2022
In the past decade Clostrdioides difficile has become a leading enteric pathogen causing antibiotic-associated diarrohoea and colitis. The manifestations range from diarrhoea to life-threatening damage to the large intestine. It is noted as a nosocomial and community acquired infection in most of the countries including India.
openaire   +2 more sources

Cutting edges in Clostridioides difficile infections

open access: yesSwiss Medical Weekly, 2021
Clostridioides difficile is the most common cause of hospital-acquired diarrhoea and one of the most important causes of hospital-acquired infections.
Ana Durovic, Sarah Tschudin-Sutter
doaj   +3 more sources

Recommendations for the management of Clostridioides difficile infection in adults and comparison with updated ACG, ESCMID and IDSA/SHEA guidelines

open access: yesFamily Medicine & Primary Care Review
Clostridioides difficile infection is the most common cause of antibiotic-associated diarrhea. IDSA/SHEA, ESCMID and ACG updated the clinical practice guidelines for CDI in 2021. This paper is an attempt to summarize these guidelines.
Mateusz Piotr Baran   +4 more
doaj   +2 more sources

Does Fecal Microbiota Transplant Have a Role in Treating Recurrent Clostridioides difficile Infection in Rural Hospitals? [PDF]

open access: yesFrontiers in Public Health, 2021
Clostridioides difficile infection possesses a significant economical burden, specifically in the inpatient and rural settings. Fecal Microbiota Transplant has been used for treatment of recurrent Clostridioides difficile but its utility is limited by ...
Krishna Vedala   +3 more
doaj   +2 more sources

Opportunities for Nanomedicine in Clostridioides difficile Infection [PDF]

open access: yesAntibiotics, 2021
Clostridioides difficile, a spore-forming bacterium, is a nosocomial infectious pathogen which can be found in animals as well. Although various antibiotics and disinfectants were developed, C. difficile infection (CDI) remains a serious health problem. C.
Pei-Wen Wang   +3 more
openaire   +4 more sources

Hospital Infection Control: Clostridioides difficile

open access: yesClinics in Colon and Rectal Surgery, 2020
Abstract Clostridioides difficile remains a leading cause of healthcare-associated infection. Efforts at C. difficile prevention have been hampered by an increasingly complex understanding of transmission patterns and a high degree of heterogeneity among existing studies. Effective prevention of C.
Turner, Nicholas A, Anderson, Deverick J
openaire   +4 more sources

Changes in the Epidemiology of Clostridioides difficile Infection [PDF]

open access: yesInfectious Disease Clinics of North America
This article describes the epidemiology of Clostridioides difficile infection (CDI) by outlining common approaches to CDI surveillance, including the application of a case definition and risk adjustment, and summarizing recent global trends in the incidence or prevalence of CDI.
Guh, Alice Y., McDonald, L. Clifford
openaire   +4 more sources

Microbiome Therapeutics for Clostridioides difficile Infection [PDF]

open access: yesInfectious Disease Clinics of North America
Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal microbiota transplant, fecal microbiota products, and live biotherapeutic products.
Lucky, Christine W.   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy